Skip to main content

Lo screening delle malattie genetiche del surrene


L’analisi genetica sta assumendo un’importanza crescente nell’ambito della patologia surrenalica sia per l’identificazione dei geni responsabili di sindromi note da tempo, ad esempio del morbo di von Hippel-Lindau, sia per il riconoscimento di nuove entità cliniche trasmesse in maniera ereditaria, ad esempio il complesso di Carney. Questo articolo si propone di passare in rassegna le patologie surrenaliche in cui è stata identificata una base genetica e illustrare le metodiche di analisi genetica più appropriate.

This is a preview of subscription content, access via your institution.


  1. 1.

    New MI. An update of congenital adrenal hyperplasia. Ann N Y Acad Sci 1038: 14, 2004.

    PubMed  Article  CAS  Google Scholar 

  2. 2.

    Yanase T. 17 alpha-hydroxylase/17, 20-lyase defects. J Steroid Biochem Mol Biol 53: 153, 1995.

    PubMed  Article  CAS  Google Scholar 

  3. 3.

    Arlt W, Walker EA, Draper N, Ivosin HE, Ride JP, Hammer F, Chalder SM, Borucka-Mankiewicz M, Hauffa BP, Malunowicz EM. Congenital adrenal hyperplasia caused by mutant P450 oxireductase and human androgen synthesis: an analytical study. Lancet 363: 2128, 2004.

    PubMed  Article  CAS  Google Scholar 

  4. 4.

    White PC, Curnow KM, Pascoe L. Disorders of steroid 1 1β-hydroxylase isoenzymes. Endocr Rev 15: 421, 1994.

    PubMed  CAS  Google Scholar 

  5. 5.

    White PC. Aldosterone synthase deficiency and related disorders. Mol Cell Endocrinol 217: 81, 2004.

    PubMed  Article  CAS  Google Scholar 

  6. 6.

    Pang S, Carbunaru G, Haider A, Copeland KC, Chang YT, Lutfallah C, Mason JI. Carriers for type II 3ß-hydroxysteroid dehydrogenase (HSD3B2) deficiency can only be identified by HSD3B2 genotype study and not by hormone test. Clin Endocrinol (Oxf) 58: 323, 2003.

    Article  CAS  Google Scholar 

  7. 7.

    Draper N, Walker EA, Bujalska IK, Tomlinson JW, Chalder SM, Arlt W, Lavery GG, Bedendo O, Ray DW, Laing I. Mutations in the genes encoding 11ß-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase interact to cause cortisone reductase deficiency. Nat Genet 34: 434, 2003.

    PubMed  Article  CAS  Google Scholar 

  8. 8.

    Bose HS, Sugawara T, Strauss JF, Miller WL. The pathophysiology and genetics of congenital lipoid adrenal hyperplasia. N Engl J Med 335: 1870, 2005.

    Article  Google Scholar 

  9. 9.

    Andersson HC, Frentz J, Martinez JE, Tuck-Muller CM, Bellizaire J. Adrenal insufficiency in Smith-Lemli-Opitz syndrome. Am J Med Genet 82: 382, 1999.

    PubMed  Article  CAS  Google Scholar 

  10. 10.

    Desai PK, Astrin KH, Thung SN, Gordon RE, Short MP, Coates PM, Desnick RJ. Cholesteryl ester storage disease: pathologic changes in an affected fetus. Am J Med Genet 26: 689, 1987.

    PubMed  Article  CAS  Google Scholar 

  11. 11.

    North K, Korson MS, Krawiecki N, Shoffner JM, Holm I. Oxidative phosphorylation defect associated with primary adrenal insufficiency. J Pediatr 128: 688, 1996.

    PubMed  Article  CAS  Google Scholar 

  12. 12.

    Ozisik G, Achermann JC, Jameson JL. The role of SF1 in adrenal in reproductive function: insight from naturally occurring mutations in humans. Mol Gen Metab 76: 85, 2002.

    Article  CAS  Google Scholar 

  13. 13.

    Muscatelli F, Strom T, Walker AP, Zanaria E, Récan D, Melndl A, Bardoni B, Guioll S, Zehetner G, Rabl W. Mutations in the DAX-1 gene give rise to both X-linked adrenal hypoplasia congenita and hypogonadotropic hypogonadism. Nature 372: 672, 1994.

    PubMed  Article  CAS  Google Scholar 

  14. 14.

    Vilain E, Le Merrer M, Lecointre C, Dsangles F, Kay MA, Maroteaux P, McCabe ERB. IMA Ge, a new clinical association of intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies. J Clin Endocrinol Metab 84: 4335, 1999.

    PubMed  Article  CAS  Google Scholar 

  15. 15.

    Laureti S, Casucci G, Santeusanio F, Angeletti G, Aubourg P, Brunetti P. X-linked adrenoleukodystrophy is a frequent cause of idiopathic Addison’s disease in young adult male patients. J Clin Endocrinol Metab 81: 470, 2005.

    Google Scholar 

  16. 16.

    Govaerts L, Monnens L, Melis T, Trijbels F. Disturbed adrenocortical function in cerebro-hepato-renal syndrome of Zellweger. Eur J Pediatr 143: 10, 1984.

    PubMed  Article  CAS  Google Scholar 

  17. 17.

    Huebner A, Elias LLK, Clark AJL. ACTH resistance syndrome. J Pediatr Endocrinol Metab 12: 277, 1999.

    PubMed  Google Scholar 

  18. 18.

    Tullio-Pelet A, Salomon R, Hadj-Rabia S, Mugnier C, de Laet MH, Chaouachi B, Bakiri F, Brottier P, Cattolico L, Penet C. Mutant WD-repeat protein in triple-A syndrome. Nat Genet 26: 332, 2000.

    PubMed  Article  CAS  Google Scholar 

  19. 19.

    Betterle C, Dal Pra C, Mantero F, Zanchetta R. Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction. Endocr Rev 23: 327, 2002.

    PubMed  Article  CAS  Google Scholar 

  20. 20.

    Fragoso MCBV, Domenice S, Latronico AC, Martin RM, Pereira MAA, Zerbini MCN, Lucon AM, Mendonça BB. Cushing’s syndrome secondary to adrenocorticotropin-independent macronodular adrenocortical hyperplasia due to activating mutations of the GNAS1 gene. J Clin Endocrinol Metab 88: 2147, 2003.

    PubMed  Article  CAS  Google Scholar 

  21. 21.

    Marchesa P, Fazio V, Church JM, McGannon E. Adrenal masses in patients with familial adenomatous polyposis. Dis Colon Rectum 40: 1023, 1997.

    PubMed  Article  CAS  Google Scholar 

  22. 22.

    Cavagnini F, Pecori Giraldi F. Adrenal causes of hypercortisolism. In: DeGroot LJ, Jameson JL (Eds). Endocrinology, Elsevier, Philadelphia, 2005.

    Google Scholar 

  23. 23.

    Kirschner LS, Carney JA, Pack SD, Taymans SE, Giatzakis C, Cho YS, Cho-Chung YS, Stratakis CA. Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex. Nat Genet 26: 89, 2000.

    PubMed  Article  CAS  Google Scholar 

  24. 24.

    Mulatero P, Veglio F, Pilon C, Rabbia F, Zocchi C, Limone P, Boscaro M, Sonino N, Fallo F. Diagnosis of glucocorticoid-remediable aldosteronism in primary aldosteronism: aldosterone response to dexamethasone and long polymerase chain reaction. J Clin Endocrinol Metab 83: 2573, 1998.

    PubMed  Article  CAS  Google Scholar 

  25. 25.

    Geller DS. Mineralocorticoid resistance. Clin Endocrinol (Oxf) 62: 513, 2005.

    Article  CAS  Google Scholar 

  26. 26.

    Scheinmann SJ, Guay-Woodford LM, Thakker RV, Warnock DG. Genetic disorders of renal electrolyte transport. N Engl J Med 340: 1177, 1999.

    Article  Google Scholar 

  27. 27.

    Palermo M, Quinkler M, Stewart PM. Apparent mineralocorticoid excess syndrome: an overview. Arq Bras Endocrinol Metab 48: 687, 2004.

    Article  Google Scholar 

  28. 28.

    Brandi ML, Gagel RF, Angeli A, Bilezikian JP, Beck-Peccoz P, Bordi C, Conte-Devolx B, Falchetti A, Gheri RG, Libroia A. Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 86: 5658, 2001.

    PubMed  Article  CAS  Google Scholar 

  29. 29.

    Neumann HPH, Bausch B, McWhinney SR, Bender BU, Gimm O, Franke G, Schipper J, Klisch J, Altehoefer C, Zerres K. Germ-line mutations in nonsyndromic pheochromocytoma. N Engl J Med 346: 1459, 2002.

    PubMed  Article  CAS  Google Scholar 

  30. 30.

    Hes FJ, Hõppener JWM, Lips CJM. Pheochromocytoma in von Hippel-Lindau disease. J Clin Endocrinol Metab 88: 969, 2003.

    PubMed  Article  CAS  Google Scholar 

  31. 31.

    Walther MM, Herring J, Enquist E, Keiser HR, Linehan WM. von Recklinghausen’s disease and pheochro-mocytomas. J Urol 162: 1582, 1999.

    PubMed  Article  CAS  Google Scholar 

Download references

Author information



Rights and permissions

Reprints and Permissions

About this article

Cite this article

Giraldi, F.P. Lo screening delle malattie genetiche del surrene. L’Endocrinologo 7, 40–61 (2006).

Download citation